American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 891-901 , November 2009

The Uremic Retention Solute p-Cresyl Sulfate and Markers of Endothelial Damage

  • Björn K.I. Meijers, MD

      Affiliations

    • Department of Medicine, Division of Nephrology, University Hospitals Leuven, Leuven, Belgium
    • ,
  • Soetkin Van kerckhoven

      Affiliations

    • Center for Molecular and Vascular Biology, Catholic University Leuven, Leuven, Belgium
    • ,
  • Kristin Verbeke, PharmD, PhD

      Affiliations

    • Department of Gastro-intestinal Research, University Hospital Leuven, Leuven, Belgium
    • ,
  • Wim Dehaen, PhD

      Affiliations

    • Department of Chemistry, Catholic University Leuven, Leuven, Belgium
    • ,
  • Yves Vanrenterghem, MD, PhD

      Affiliations

    • Department of Medicine, Division of Nephrology, University Hospitals Leuven, Leuven, Belgium
    • ,
  • Marc F. Hoylaerts, PhD

      Affiliations

    • Center for Molecular and Vascular Biology, Catholic University Leuven, Leuven, Belgium
    • ,
  • Pieter Evenepoel, MD, PhD

      Affiliations

    • Department of Medicine, Division of Nephrology, University Hospitals Leuven, Leuven, Belgium
    • Corresponding Author InformationAddress correspondence to Pieter Evenepoel, MD, PhD, Dienst nefrologie, Universitair Ziekenhuis Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium

Received 8 December 2008 ,Accepted 3 April 2009.

References 

  1. Sarnak M, Levey A. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis. 2000;35(suppl 1):S117–S131
  2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  3. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
  4. Meijers BKI, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int. 2008;73:1173–1180
  5. Schiffrin EL, Lipman ML, Mann JFE. Chronic kidney disease: Effects on the cardiovascular system. Circulation. 2007;116:85–97
  6. Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction (Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension). J Hypertens. 2005;23:7–17
  7. Dou L, Bertrand E, Cerini C, et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int. 2004;65:442–451
  8. Faure V, Dou L, Sabatier F, et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost. 2006;3:566–573
  9. Cerini C, Dou L, Anfosso F, et al. p-Cresol, an uremic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost. 2004;92:140–150
  10. Boulanger CM, Scoazec A, Ebrahimian T, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation. 2001;104:2649–2652
  11. Amabile N, Guerin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005;16:3381–3388
  12. Abid Hussein MN, Böing AN, Sturk A, Hau CM, Nieuwland R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost. 2007;98:1096–1107
  13. Martinez AW, Recht NS, Hostetter TH, Meyer TW. Removal of p-cresol sulfate by hemodialysis. J Am Soc Nephrol. 2005;16:3430–3436
  14. de Loor H, Bammens B, Evenepoel P, De Preter V, Verbeke K. Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum. Clin Chem. 2005;51:1535–1538
  15. Gamage N, Barnett A, Hempel N, et al. Human sulfotransferases and their role in chemical metabolism. Toxicol Sci. 2006;90:5–22
  16. Schepers E, Meert N, Glorieux G, Goeman J, Van der Eycken J, Vanholder R. p-Cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant. 2007;22:592–596
  17. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant. 2002;17:1085–1092
  18. Enjeti A, Lincz L, Seldon M. Detection and measurement of microparticles: An evolving research tool for vascular biology. Semin Thromb Hemost. 2007;33:771–779
  19. Feigenbaum J, Neuberg C. Simplified method for the preparation of aromatic sulfuric acid esters. J Am Chem Soc. 1941;63:3529–3530
  20. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: Potentially pathogenic agents and diagnostic markers. Transfus Med Rev. 2006;20:1–26
  21. Bernal-Mizrachi L, Jy W, Jimenez J, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J. 2003;145:962–970
  22. Simak J, Gelderman MP, Yu H, Wright V, Baird A. Circulating endothelial microparticles in acute ischemic stroke: A link to severity, lesion volume and outcome. J Thromb Haemost. 2006;4:1296–1302
  23. Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol. 2005;45:1467–1471
  24. Al-Massarani G, Vacher-Coponat H, Paul P, et al. Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation. Am J Transplant. 2008;8:2360–2367
  25. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–2218
  26. Teng M, Wolf M, Ofsthun MN, et al. Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol. 2005;16:1115–1125
  27. Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol. 2001;3:339–345
  28. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95–105
  29. Lesaffer G, De Smet R, Belpaire FM, et al. Urinary excretion of the uraemic toxin p-cresol in the rat: Contribution of glucuronidation to its metabolization. Nephrol Dial Transplant. 2003;18:1299–1306
  30. Depner T, Himmelfarb J. Uremic retention solutes: The free and the bound. J Am Soc Nephrol. 2007;18:675–676
  31. Meyer TW, Peattie JW, Miller JD, et al. Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. J Am Soc Nephrol. 2007;18:868–874
  32. Meijers BKI, Weber V, Bammens B, et al. Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption. Artif Organs. 2008;32:214–219

 Originally published online as doi: 10.1053/j.ajkd.2009.04.022 on July 21, 2009.

PII: S0272-6386(09)00726-4

doi: 10.1053/j.ajkd.2009.04.022

American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 891-901 , November 2009

Article Tools

* Image Usage & Resolution